Joanna Horobin is Director of Vyant Bio, Inc.. Currently has a direct ownership of 23,123 shares of VYNT, which is worth approximately $0. The most recent transaction as insider was on Jan 17, 2023, when has been sold 7,526 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1K
0% 3M change
0% 12M change
Total Value Held $0

Joanna Horobin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2023
BUY
Grant, award, or other acquisition
-
7,526 Added 24.56%
23,123 Common Stock, $0.0001 ...
Oct 17 2022
BUY
Grant, award, or other acquisition
-
14,285 Added 15.48%
77,994 Common Stock, $0.0001 ...
Jul 18 2022
BUY
Grant, award, or other acquisition
-
8,092 Added 11.27%
63,709 Common Stock, $0.0001 ...
Apr 18 2022
BUY
Grant, award, or other acquisition
-
6,796 Added 10.89%
55,617 Common Stock, $0.0001 ...
Mar 30 2022
BUY
Grant, award, or other acquisition
-
43,478 Added 47.11%
48,821 Common Stock, $0.0001 ...
Jan 18 2022
BUY
Grant, award, or other acquisition
$6,999 $1.31 p/Share
5,343 Added 50.0%
5,343 Common Stock, $0.0001 ...

Also insider at

LQDA
Liquidia Corp Healthcare
KYMR
Kymera Therapeutics, Inc. Healthcare
JH

Joanna Horobin

Director
Cherry Hill,, NJ

Track Institutional and Insider Activities on VYNT

Follow Vyant Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNT shares.

Notify only if

Insider Trading

Get notified when an Vyant Bio, Inc. insider buys or sells VYNT shares.

Notify only if

News

Receive news related to Vyant Bio, Inc.

Track Activities on VYNT